Cargando…

Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model

PURPOSE: Berberine (BBR) is an active component of Phellodendri Cortex (PC), which is a traditional Chinese medicine that has been prescribed clinically for hyperuricemia (HUA) for hundreds of years. Many studies reported the anti-inflammatory and nephroprotective properties of BBR and PC; however,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiaoping, Huang, Ziwei, Liu, Defu, Zheng, Jingna, Xie, Jianhui, Chen, Jiannan, Zeng, Huifang, Su, Ziren, Li, Yucui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326381/ https://www.ncbi.nlm.nih.gov/pubmed/34349501 http://dx.doi.org/10.2147/DDDT.S317776

Ejemplares similares

Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
por: Xu, Lieqiang, et al.
Publicado: (2022)

Self-Assembled nanoparticles Combining Berberine and Sodium Taurocholate for Enhanced Anti-Hyperuricemia Effect
por: Qin, Zehui, et al.
Publicado: (2023)

Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System
por: Li, Minhua, et al.
Publicado: (2022)

Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells
por: Zheng, Jingna, et al.
Publicado: (2023)

Gut Microbiota-Mediated Transformation of Coptisine Into a Novel Metabolite 8-Oxocoptisine: Insight Into Its Superior Anti-Colitis Effect
por: Ai, Gaoxiang, et al.
Publicado: (2021)

The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics
por: Yu, Qiuxia, et al.
Publicado: (2022)

Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation
por: Song, Lei, et al.
Publicado: (2019)

Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
por: Xu, Lieqiang, et al.
Publicado: (2021)

Effect of supercritical carbon dioxide fluid extract from Chrysanthemum indicum Linné on bleomycin-induced pulmonary fibrosis
por: Nie, Juan, et al.
Publicado: (2021)

Berberine and Berberine-Containing Plants in Pharmacology and Therapeutics
por: Chopra, R. N., et al.
Publicado: (1932)

Pharmacological effects of berberine on mood disorders
por: Fan, Jie, et al.
Publicado: (2018)

Protective Effect of Pogostone on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis via Inhibition of T Helper Cell
por: Su, Jiyan, et al.
Publicado: (2017)

Pharmacological effects of Chatuphalatika in hyperuricemia of gout
por: Sato, Vilasinee Hirunpanich, et al.
Publicado: (2018)

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
por: Xie, Xuejiao, et al.
Publicado: (2020)

Chongcao-Shencha Attenuates Liver and Kidney Injury through Attenuating Oxidative Stress and Inflammatory Response in D-Galactose-Treated Mice
por: Li, Cailan, et al.
Publicado: (2016)

Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
por: Huang, Guoqing, et al.
Publicado: (2022)

The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
por: Wang, Yanzhe, et al.
Publicado: (2023)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

Influence of occupational exposure on hyperuricemia in steelworkers: a nested case–control study
por: Chen, Yuanyu, et al.
Publicado: (2022)

Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (−)-Guaiol Against Lung Adenocarcinoma
por: Zeng, Yaoying, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
por: Han, Yunfeng, et al.
Publicado: (2021)

Research progress on the pharmacological effects of berberine targeting mitochondria
por: Fang, Xinyi, et al.
Publicado: (2022)

Recent studies on berberine and its biological and pharmacological activities
por: Nadalin, Priscilla, et al.
Publicado: (2023)

Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology
por: Xue, Wu, et al.
Publicado: (2022)

The Effect of Berberine, a Drug From Chinese Folk Medicine, on Serum and Urinary Uric Acid Levels in Rats With Hyperuricemia
por: Naz, Hira, et al.
Publicado: (2021)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency
por: Yan, Meng, et al.
Publicado: (2015)

Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology
por: Liu, Pei, et al.
Publicado: (2020)

Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Chongcaoyishen Decoction Against Chronic Kidney Disease
por: Fan, Zhenliang, et al.
Publicado: (2022)

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones
por: Liu, Haizhao, et al.
Publicado: (2023)

Traditional Chinese Herbal Medicine Plays a Role in the Liver, Kidney, and Intestine to Ameliorate Hyperuricemia according to Experimental Studies
por: Xu, Li, et al.
Publicado: (2021)

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
por: Zhang, Chaohe, et al.
Publicado: (2020)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

A novel mouse model of hyperuricemia and gouty nephropathy
por: Guan, Jin, et al.
Publicado: (2020)

Impaired intestinal barrier function in a mouse model of hyperuricemia
por: Guo, Yingjie, et al.
Publicado: (2019)

T cell inhibition by pogostone from Pogostemon cablin (Blanco) Benth: In vitro and in vivo immunosuppressive analysis
por: Su, Jiyan, et al.
Publicado: (2017)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021)

Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
por: Chen, Yuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jc84ju3d3pio5umnmtv171i1h